Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Soiken Holdings Inc
2385Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for pharmaceutical clinical research and epidemiology studies; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. The company was incorporated in 1994 and is headquartered in Toyonaka, Japan. Address: Senri Life Science Center, Toyonaka, Japan, 560-0082
Analytics
WallStreetin tavoitehinta
93 431.85 JPYP/E-suhde
–Osinkotuotto
3.66 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut 2385
Osinkoanalytiikka 2385
Osinkojen kasvu 5 vuoden aikana
150 %Jatkuva kasvu
–Maksusuhde 5 vuoden keskiarvo
20 %Osinkohistoria 2385
Osakkeen arvostus 2385
Talousasiat 2385
Tuloksia | 2019 | Dynamiikka |